Company intelligence / Profile preview

Theronomic

Australia

Ownership: Private
Development stage: Other

Overview

Theronomic's flagship product, Tribiotic Gut Shield, has shown improvements in digestion, immune support, and overall well-being in user reviews and has been recognized with the Product of the Year: Microbiome Modulation award at the 2024 NutraIngredients-Asia Awards; it is a supplement with prebiotic, probiotic, and postbiotic components and is commercially available[6][4][1].

Therapeutic areas: GastroenterologyOtherImmunology
Modalities: ProbioticPrebioticPostbiotic
Industry: Food & Nutrition

Partnerships

Anagenix (ingredient and marketing partnership for Livaux®)[1]Ingredients-Plus (distributor in Australia)[1]Access Group (collaboration partner)[1]

Beyond the preview

Go deeper on Theronomic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theronomic.

Explore the full profile